Cargando…
Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study
This study investigated the incidence of and risk factors for herpes zoster in patients with non-Hodgkin lymphoma (NHL) who were receiving anti-lymphoma treatment. The overall incidence density of herpes zoster was 12.21% (472/3865); 11.79% (258/2188) of the patients received conventional chemothera...
Autores principales: | Cho, Shih-Feng, Wu, Wan-Hsuan, Yang, Yi-Hsin, Liu, Yi-Chang, Hsiao, Hui-Hua, Chang, Chao-Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585724/ https://www.ncbi.nlm.nih.gov/pubmed/26391893 http://dx.doi.org/10.1038/srep14008 |
Ejemplares similares
-
Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - A nationwide population-based matched-control study in Taiwan
por: Liu, Yi-Chang, et al.
Publicado: (2012) -
Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017) -
Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study
por: Cho, Shih-Feng, et al.
Publicado: (2015) -
Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study
por: Wu, Chieh-Hsin, et al.
Publicado: (2016) -
Radiotherapy combined with chemotherapy increases the risk of herpes zoster in patients with gynecological cancers: a nationwide cohort study
por: Lee, Peng-Yi, et al.
Publicado: (2020)